The 616 nm detection wavelength differs from Hb's 415 nm absorption peak; however, MetHb (absorption peak at 630 nm, which is near 616 nm) may interfere in pathological states (e.g., methemoglobinemia), warranting future research on methemoglobin interference mitigation. Here, GSTM1 is linked to methemoglobinemia.